Bausch Health Cos Gross Profit 2012-2026 | BHC
Bausch Health Cos gross profit from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Bausch Health Cos Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $7,253 |
| 2024 | $6,843 |
| 2023 | $6,198 |
| 2022 | $5,760 |
| 2021 | $6,040 |
| 2020 | $5,778 |
| 2019 | $6,251 |
| 2018 | $6,029 |
| 2017 | $6,176 |
| 2016 | $7,063 |
| 2015 | $7,862 |
| 2014 | $5,970 |
| 2013 | $3,865 |
| 2012 | $2,511 |
| 2011 | $1,731 |
|
Bausch Health Cos Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-03-31 | $1,786 |
| 2025-12-31 | $1,998 |
| 2025-09-30 | $1,931 |
| 2025-06-30 | $1,766 |
| 2025-03-31 | $1,558 |
| 2024-12-31 | $1,832 |
| 2024-09-30 | $1,814 |
| 2024-06-30 | $1,684 |
| 2024-03-31 | $1,513 |
| 2023-12-31 | $1,703 |
| 2023-09-30 | $1,615 |
| 2023-06-30 | $1,518 |
| 2023-03-31 | $1,362 |
| 2022-12-31 | $1,541 |
| 2022-09-30 | $1,462 |
| 2022-06-30 | $1,390 |
| 2022-03-31 | $1,367 |
| 2021-12-31 | $1,570 |
| 2021-09-30 | $1,529 |
| 2021-06-30 | $1,488 |
| 2021-03-31 | $1,453 |
| 2020-12-31 | $1,568 |
| 2020-09-30 | $1,548 |
| 2020-06-30 | $1,169 |
| 2020-03-31 | $1,493 |
| 2019-12-31 | $1,589 |
| 2019-09-30 | $1,625 |
| 2019-06-30 | $1,558 |
| 2019-03-31 | $1,479 |
| 2018-12-31 | $1,519 |
| 2018-09-30 | $1,554 |
| 2018-06-30 | $1,534 |
| 2018-03-31 | $1,422 |
| 2017-12-31 | $1,516 |
| 2017-09-30 | $1,560 |
| 2017-06-30 | $1,587 |
| 2017-03-31 | $1,513 |
| 2016-12-31 | $1,738 |
| 2016-09-30 | $1,821 |
| 2016-06-30 | $1,762 |
| 2016-03-31 | $1,742 |
| 2015-12-31 | $2,028 |
| 2015-09-30 | $2,139 |
| 2015-06-30 | $2,047 |
| 2015-03-31 | $1,648 |
| 2014-12-31 | $1,651 |
| 2014-09-30 | $1,495 |
| 2014-06-30 | $1,456 |
| 2014-03-31 | $1,368 |
| 2013-12-31 | $1,332 |
| 2013-09-30 | $967 |
| 2013-06-30 | $798 |
| 2013-03-31 | $768 |
| 2012-12-31 | $702 |
| 2012-09-30 | $654 |
| 2012-06-30 | $610 |
| 2012-03-31 | $544 |
| 2011-12-31 | $499 |
| 2011-09-30 | $435 |
| 2011-06-30 | $436 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |